HCA Healthcare reports higher revenue and EPS in third quarter
Filed with the SEC on · Summarized by InvestorsBot
HCA Healthcare reported third-quarter 2026 revenue of $19.849 billion, up 3.6% year over year, while net income fell 3.9% to $1.579 billion; diluted EPS rose 4.5% to $7.27 and Adjusted EBITDA increased 1.2% to $3.918 billion. Same-facility equivalent admissions grew 3.0%, but an increase in uninsured patients reduced pretax income by approximately $400 million; HCA expects full-year 2026 results in the upper half of its previously issued guidance ranges of $77.0 billion-$79.5 billion in revenue and $28.70-$30.50 in EPS.